Zuan-Fu Lim, a cancer cell biology graduate student in Patrick Ma’s lab at the WVU Cancer Institute, has received an American Association of Immunologists Young Investigator Award for his first place oral presentation at the 21st annual meeting of the Translational Research Cancer Centers Consortium at Seven Springs, PA.
Lung cancer cells can adopt various mechanisms of resistance to precision therapy. Lim’s research focused specifically on non-small cell lung cancers (NSCLCs) characterized by chromosomal abnormalities in the ALK gene and found that precision therapy targeting the ALK gene may not be effective because molecular drug resistance can emerge in a non-genetic fashion.
Pictured: David Klinke, PhD, of the WVU Cancer Institute congratulates Zuan-Fu Lim, a cancer cell biology graduate student, for winning an American Association of Immunologists Young Investigator Award.
WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors
The WVU Cancer Institute is participating in the implementation of a new drug therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a type of tumor that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix. These life-threatening tumors can spread to other organs, such as the liver.
Meshea Poore, vice president for the Division of Diversity, Equity and Inclusion at WVU, will be the special guest at a Health Sciences Town Hall during WVU’s Diversity Week celebrations.
With severe storm approaching the East Coast, WVU reminds campus community about safety and resources
The West Virginia University Police and Office of Emergency Management urges students, faculty and staff to be prepared as the state braces for the impact of Hurricane Florence, making landfall along the East Coast later this week.